Jay Venkatesan - Jun 24, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Stock symbol: ELTX
Transactions as of: Jun 24, 2021
Transactions value $: -$379,278
Form type: 4
Date filed: 12/17/2021, 04:13 PM
Previous filing: May 27, 2022
Next filing: Sep 21, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Tax liability	-$566K	-41.1K	-3.21%	$13.78	1.24M	Jun 24, 2021	Direct	F1
transaction	ELTX	Common Stock	Purchase	$187K	+77.6K	+6.26%	$2.41^*	1.32M	Dec 15, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").

Remarks:

President and Chief Executive Officer and Director